Get notified when HIMS files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: HIMS Hims & Hers Health, Inc. 8-K

Hims & Hers establishes $400M receivables purchase facility with JPMorgan

Filed July 1, 2026 · Period ending June 26, 2026 · ~1 min read

Key Changes

  • high

    Two HIMS subsidiaries entered a $400M receivables purchase facility with JPMorgan, allowing them to sell eligible receivables at a discount for immediate cash. JPMorgan retains discretion to decline purchases. Initial 364-day term with indefinite one-year extension options.

    Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
  • medium

    HIMS guaranteed its subsidiaries will perform their obligations under the facility but explicitly did not guarantee receivables collectability or subsidiary creditworthiness, limiting parent exposure to operational performance rather than credit risk.

    Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
  • medium

    HIMS amended its existing revolving credit agreement to permit the receivables facility and carved out a $400M basket for related indebtedness. Interest rates, fees, covenants, and default provisions remain otherwise unchanged.

    Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ISNR 10-Q) is open in full — no account needed.

Partner

Trade HIMS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jul 20, 2026 · How we verify